3 Axis Advisors
@3AxisAdvisors
3 Axis Advisors specializes in the disruptive simplification of the prescription drug supply chain.
ID:1088265347894071297
https://www.3axisadvisors.com/ 24-01-2019 02:40:52
329 Tweets
770 Followers
119 Following
Follow People
“What makes this situation unique is that CVS has not selected the cheapest product, so it’s ‘propping up a more inflated version than what the marketplace is otherwise bearing.’”
endpts.com/sandozs-humira… Zach Brennan Antonio Ciaccia Mark Cuban Mark Cuban Cost Plus Drug Company
'How can we continue to provide benefits in a system where the vendor's incentives are in direct conflict with that of the plan sponsor and the patient? You know, the theme here is transparency.' - Antonio Ciaccia, President, 3 Axis Advisors
To watch the full event visit:…
“You can add lawsuits like this to the mountain of reasons to create greater clarity, guardrails, and accountability within the 340B program.” - Antonio Ciaccia
statnews.com/pharmalot/2024… pharmalot ed silverman
What Ohio leaders are doing to fight increasing costs for prescription drugs Anna Staver Marty Schladen Antonio Ciaccia All Sides wosu.org/show/all-sides…
“The thing that makes us most unique is this kickback scheme that ultimately enables and rewards intermediaries and middlemen at the expense of the end-paying consumer.” - Antonio Ciaccia
abc6onyourside.com/news/local/in-… Darrel Rowland WSYX ABC 6
Merck, J&J and Bristol Myers CEOs face drug-pricing grilling on Capitol Hill, but experts cite deeper problems under the radar Eleanor Laise Antonio Ciaccia Adam J. Fein marketwatch.com/story/merck-j-…
Pharmacy benefits contractor for West Virginia public employees system pays itself way more for some drugs than necessary Marty Schladen Mark Cuban Cost Plus Drug Company ohiocapitaljournal.com/2024/02/06/con…
This week, Antonio Ciaccia joined CBS Detroit to discuss federal efforts to combat rising prescription drug costs and why big PBMs are under fire for their role in undermining traditional market forces that could yield better savings for consumers. cbsnews.com/detroit/video/…
“That’s the sad part about this system. Formularies are often used to direct patients to medicines that might actually be more expensive for them, in order to generate rebates that accrue to others.” - Antonio Ciaccia
managedhealthcareexecutive.com/view/2024-form… Denise Myshko Managed Healthcare Mark Cuban
CVS Caremark to remove branded Humira from formularies … from a certain point of view Denise Myshko Antonio Ciaccia Mark Cuban Cost Plus Drug Company formularywatch.com/view/cvs-carem…
Exclusive: Drugmakers set to raise US prices on at least 500 drugs in January Michael Erman Patrick Wingrove reuters.com/business/healt…
Great use of NADAC in this Cecilia Garzella piece on ADHD drug shortages and their impact on patient access to treatment usatoday.com/story/news/inv…
Insulin, PBM lawsuits seen as alternative to pricing legislation Celine Castronuovo Antonio Ciaccia news.bloomberglaw.com/health-law-and…
Check out Antonio Ciaccia’s thoughts in The New York Times about the CVS announcement of a new program that will alter the way they price medicines – but may not actually change their underlying finances nor eliminate the dysfunction that continues to plague the industry nytimes.com/2023/12/05/bus…
Follow Antonio Ciaccia, who is probably the most important thinker and analyst in health care in America. Just a national treasure.